Showing results (31-40 of 120) with videos related to
Sort By:
Pageof 12
Mabs|August 30, 2012
Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodiesShubhada N Joshi, David C Butler, Anne MesserCancer Informatics|April 2, 2021
Pan-Cancer Transcriptional Models Predicting Chemosensitivity in Human TumorsJason D Wells, Jacqueline R Griffin, Todd W MillerJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2011
Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancerTodd W Miller, Justin M Balko, Carlos L ArteagaFrontiers in Oncology|October 23, 2012
Abrogating endocrine resistance by targeting ERα and PI3K in breast cancerEmily M Fox, Carlos L Arteaga, Todd W MillerJournal of Cellular Biochemistry|May 6, 2016
Clinical Implementation of Novel Targeted Therapeutics in Advanced Breast CancerMary D Chamberlin, Erica B Bernhardt, Todd W MillerMolecular Therapy : the Journal of the American Society of Gene Therapy|November 27, 2004
A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synucleinChun Zhou, Sharareh Emadi, Michael R Sierks, et al.Plos One|November 5, 2019
Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapyKevin Shee, Jason D Wells, Amanda Jiang, et al.Journal of Neuropathology and Experimental Neurology|September 15, 2010
Early or late-stage anti-N-terminal Huntingtin intrabody gene therapy reduces pathological features in B6.HDR6/1 miceAbigail Snyder-Keller, Julie A McLear, Tyisha Hathorn, et al.Protein Engineering, Design & Selection : PEDS|April 10, 2010
Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasmErik Kvam, Michael R Sierks, Charles B Shoemaker, et al.Human Molecular Genetics|August 27, 2015
Transcriptional dysregulation of inflammatory/immune pathways after active vaccination against Huntington's diseaseArlene I Ramsingh, Kevin Manley, Yinghui Rong, et al.Pageof 12